ZRO — Biosenta Share Price
Last trade - 00:00- CA$10.12m
- CA$10.15m
- CA$0.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6,098.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -199460.84% | ||
Financial Summary
| Year End 30th Sep | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0.02 | 0 | n/a | 0 | 0.17 | n/a | n/a | 15.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biosenta Inc. is a Canada-based company that is engaged in the development and manufacturing of a range of chemical compounds for household and industrial applications using its encapsulated nanotechnology. The Company is engaged in developing sales for True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product. Its disinfectants and cleaners are focused on eliminating mold, fungi, bacteria and viruses on contact and preventing regrowth. The Company's industrial compounds are embedded to protect various materials, including drywall, plastic and resins from microbe formation. Its compounds remain to protect the drywall of buildings and objects, such as resin furniture, and carpet rubber backing and synthetic tufts, which contain plastic or resin, as well as textiles and paper.
Directors
- Last Annual
- September 30th, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- August 20th, 1986
- Public Since
- May 25th, 1994
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 23,006,591
- Address
- 18 Wynford Drive, Suite 704, TORONTO, M3C 3S2
- Web
- https://www.biosenta.com
- Phone
- +1 4164102019
- Auditors
- MS Partners LLP
Upcoming Events for ZRO
Similar to ZRO
CleanGo Innovations
Canadian Securities Exchange
FAQ
As of Today at 01:03 UTC, shares in Biosenta are trading at CA$0.44. This share price information is delayed by 15 minutes.
Shares in Biosenta last closed at CA$0.44 and the price had moved by -16.98% over the past 365 days. In terms of relative price strength the Biosenta share price has underperformed the Toronto Stock Exchange 300 Composite Index by -12.85% over the past year.
There is no consensus recommendation for this security.
Biosenta does not currently pay a dividend.
Biosenta does not currently pay a dividend.
Biosenta does not currently pay a dividend.
To buy shares in Biosenta you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.44, shares in Biosenta had a market capitalisation of CA$10.12m.
Here are the trading details for Biosenta:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: ZRO
Based on an overall assessment of its quality, value and momentum Biosenta is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosenta. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -0.31%.
As of the last closing price of CA$0.44, shares in Biosenta were trading -14.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biosenta PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Biosenta's directors